Leidos

Leidos

Price: 121.69

Company and Business Model

Leidos Holdings, Inc. is a defense, aviation, information technology, and biomedical research company. It operates through various segments, including Defense Solutions, Civil, and Health. Core products and services encompass systems integration, software development, and data analytics, primarily serving government and commercial clients. Major revenue sources include contracts with the U.S. Department of Defense and other federal agencies, as well as commercial contracts in healthcare and civil sectors.

Investment Profile

The investment profile of Leidos is more aligned with balanced investors, given its moderate dividend yield and stable revenue streams. The company exhibits characteristics suitable for those seeking a mix of growth and income, though recent revenue trends indicate some volatility. Investors may find it appealing for its potential stability in the industrial sector.

Official website

Fundamental metrics (experimental)

EPS (TTM) — earnings per share for the last 12 months, $
11.03 OK
Revenue QoQ — quarter-over-quarter revenue growth
4.6%
EPS surprise
7.4% better than expected
20d volatility
1.6% stable
Dividend yield
1.7% moderate last ex-date: 2026-06-15
FMP / FinFeed data updated: 2026-06-09

Forecast impact

negative
Rating Downgraded · Jefferies · valid until 2026-07-03 · updated 2026-06-11
Target +15.1% target fill 86.9%
Reaction D5 +1.18% · D10 pending market trust
Impact Potential -4 · Risk +3 up to 30 days or until target is reached
Reco: Sell Potential: 24 Risk: 75 Updated: 2026-06-11 05:22
How recommendation works
Why AI thinks so:
Weak momentum and high risk overshadow fundamentals.

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
AI recommendation changes
Date Before After Reason
2026-06-03 02:45 Hold Sell Weak fundamentals and negative momentum signal high risk.
2026-05-08 15:15 Hold Weak fundamentals and negative momentum raise significant risk.
2026-05-05 02:59 Sell Hold Компания демонстрирует смешанные результаты, с недавним снижением выручки и волатильностью акций. Однако, положительный сюрприз по EPS и дивидендная доходность могут привлечь инвесторов.
Analyst forecasts
Date Analyst Action Target Price Then
2026-06-03 10:08 Jefferies Rating Downgraded — → 140 126.82
2026-05-27 15:27 BNP Paribas Update — → 165 131.78
2026-04-08 13:24 Jefferies Target Lowered 215 → 185 160.64

Nothing yet